Proceedings: Further studies on the mode of action of ergotamine on canine vein strips.
D000818:Animals; D003042:Cocaine / Q000494:pharmacology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D004837:Epinephrine / Q000378:metabolism; D004878:Ergotamine / Q000494:pharmacology*; D005268:Femoral Vein / Q000187:drug effects; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology; D011941:Receptors, Adrenergic / Q000187:drug effects; D012501:Saphenous Vein / Q000187:drug effects; D014439:Tyramine / Q000494:pharmacology; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014680:Veins / Q000187:drug effects*
D011453:Prostaglandins; D011941:Receptors, Adrenergic; D014662:Vasoconstrictor Agents; D003042:Cocaine; D004878:Ergotamine; D009638:Norepinephrine; D014439:Tyramine; D007213:Indomethacin; D004837:Epinephrine; D010646:Phentolamine